Compare CSCO & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSCO | TMO |
|---|---|---|
| Founded | 1984 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Industrial Machinery/Components |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.5B | 164.3B |
| IPO Year | 2003 | 1996 |
| Metric | CSCO | TMO |
|---|---|---|
| Price | $121.14 | $590.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 18 |
| Target Price | $89.80 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 18.8M | 2.1M |
| Earning Date | 05-13-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.88% | 0.40% |
| EPS Growth | 0.39 | ★ 7.32 |
| EPS | 2.36 | ★ 9.10 |
| Revenue | ★ $49,330,000,000.00 | $20,918,000,000.00 |
| Revenue This Year | $10.86 | $6.55 |
| Revenue Next Year | $4.60 | $5.11 |
| P/E Ratio | ★ $51.48 | $63.74 |
| Revenue Growth | 2.76 | ★ 14.47 |
| 52 Week Low | $65.80 | $435.27 |
| 52 Week High | $130.37 | $643.99 |
| Indicator | CSCO | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 61.34 | 67.57 |
| Support Level | $112.61 | $555.69 |
| Resistance Level | $122.25 | $596.47 |
| Average True Range (ATR) | 2.99 | 15.78 |
| MACD | 1.04 | 0.23 |
| Stochastic Oscillator | 80.01 | 90.87 |
Cisco Systems is the largest provider of networking equipment in the world and one of the largest software companies in the world. Its largest businesses are selling networking hardware and software (where it has leading market shares) and cybersecurity software such as firewalls. It also has collaboration products, like its Webex suite, and observability tools. It primarily outsources its manufacturing to third parties and has a large sales and marketing staff—25,000 strong across 90 countries. Overall, Cisco employs 80,000 people and sells its products globally.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).